氟伐他汀对高血压病患者血压与C反应蛋白和白介素6的影响被引量：6

导出

摘要高血压病是多种心、脑血管疾病的重要病因和危险因素，影响重要脏器例如心、脑、肾的结构和功能，最终导致这些器官的功能衰竭。他汀类调脂药除具有调脂作用外，还有抗炎作用。本研究旨在探讨他汀类调脂药对高血压病患者血压与C反应蛋白和白介素6（IL-6）的影响。

作者董旭刘素云毕建成张建英

机构地区河北医科大学中医院急诊科河北医科大学第二医院心内科河北医科大学中医院检验科

出处《中华心血管病杂志》 CAS CSCD 北大核心 2008年第4期344-345,共2页 Chinese Journal of Cardiology

基金河北省科技攻关项目（062761281）

关键词 C反应蛋白高血压病白介素6 患者血压氟伐他汀他汀类调脂药脑血管疾病危险因素

分类号 R686 [医药卫生—骨科学]

引文网络
相关文献

参考文献8

1Hayaishi-Okano R, Yamasaki Y, Katakami N, et al. Elevated Creactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabets. Diabetes Care, 2002,25 : 1432-1438.
2Fichtlscherer S, Rosenberger G, Walter DH, et al. Elevated Creactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation ,2000,102 : 1000- 1006.
3Bhagat K, Valance P. Inflammatory cytokines impair endothelium- dependent dilatation in human veins in vivo. Circulation, 1997,96: 3042 -3047.
4李建军.高血压可能是一种炎症相关性疾病[J].高血压杂志,2005,13(9):526-527. 被引量：46
5吴寿岭,吴云涛,刘国仗,郝冰,张琦,袁保军.白细胞介素-6与原发性高血压相关性研究[J].中国循环杂志,2004,19(2):151-151. 被引量：19
6邓华菲,熊燕.他汀类药物的非降脂作用与心血管保护[J].中国医师杂志,2004,6(4):572-573. 被引量：15
7赵水平.他汀类药物非降脂作用研究现状[J].医学临床研究,2004,21(1):1-2. 被引量：40
8Kwak BR, Mach F. Statins inhibit leukocyte recruitment: new evidence for their anti-inflammatory properties. Arterioscler Thromb Vasc Biol,2001, 21 : 1256-1258.

二级参考文献12

1Laufs U,Gertz K,Huang P,et al.Atorvastatin upregulates type III nitric oxide synthase in thrombocytes,decreases platelet activation,and protects from cerebral ischemia in normocholesterolemic mice[J].Stroke,2000,31(10):2442-2449
2Undas A,Brummel KE,Musial J,et al.Simvastatin depresses blood clotting by inhibiting activation of prothrombin,factor V,and factor XIII and by enhancing factor Va inactivation[J].Circulation,2001,103(18):2248-2253
3Werner N,Priller J,Laufs U,et al.Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation:effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition[J].Arterioscler Thromb Vasc Biol,2002,22(10):1567-15
4Li D,Chen H,Romeo F,et al.Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells:role of LOX-1[J].J Pharmacol Exp Ther,2002,302(2):601-5
5Silva EP,Fonseca FA,Ihara SS,et al.Early benefits of pravastatin to experimentally induced atherosclerosis[J].J Cardiovasc Pharmacol,2002,39(3):389-395
6Wassman S,Faul A,Hennen B,et al.Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function[J].Circ Res,2003,93(9):e98-e103
7Tsunekawa T,Hayashi T,Kano H,et al.Cerivastatin,a hydroxymethylglutaryl coenzyme a reductase inhibitor,improves endothelial function in elderly diabetic patients within 3 days [J].Circulation,2001,104(4):376-379
8Laufs U,Gertz K,Dirnagl U,et al.Rosuvastatin,a new HMG-CoA reductase inhibitor,upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice[J].Brain Res,2002,942(1-2):23-30
9Vasa M,Fichtlscherer S,Adler K,et al.Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease[J].Circulation,2001,103(24):2885-2890
10Bellosta S,Ferri N,Arnaboldi L,et al.Pleiotropic effects of statins in atherosclerosis and diabetes[J].Diabetes Care,2000,23 Suppl 2:B72-B78